MitoSense Inc. is a biotechnology company dedicated to advancing mitochondrial health through innovative therapies and research, focusing on treatments for neurodegenerative diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/22/24 | $3,500,000 | Seed |
Caydan Capital Partners | undisclosed |
